Face exosome therapy for skin quality
The service is designed for patients seeking a more regenerative approach to dullness, texture irregularity, post-procedure recovery support, or visible skin fatigue. The planning conversation reviews pigmentation tendency, acne history, sensitivity, current skin care actives, recent procedures, and expected downtime. This helps keep the protocol measured and medically sensible.
Treatment planning and care sequence
iMedi frames face exosome therapy as part of a larger aesthetic plan, not an isolated trend. The care sequence may include skin preparation, suitability review, procedure planning, recovery guidance, and follow-up. Patients are advised on sun care, active ingredient use, and how exosome-led care can fit with microneedling or other skin procedures when appropriate.
Realistic outcomes and safety
The goal is to support skin resilience and visible quality over time. Results vary based on age, skin condition, lifestyle, inflammation, pigmentation risk, and prior procedures. iMedi avoids guaranteed anti-aging claims and instead focuses on careful selection, expectation-setting, and follow-up.
How iMedi keeps the plan focused
- Suitability is reviewed before a procedure or device-led protocol is recommended.
- The service is connected to its parent care pathway instead of being sold as a duplicate package.
- Expected benefits, limits, aftercare, and follow-up needs are discussed clearly.
Frequently Asked Questions
Who is a good candidate for face exosome therapy?
Adults seeking skin-quality support may be candidates after review of skin type, sensitivity, pigmentation risk, and recent procedures.
Can exosomes be combined with microneedling?
They may be considered alongside microneedling in selected cases, but the sequence should be planned after clinical review.
Is there downtime?
Downtime depends on the delivery method and skin sensitivity. The team will explain recovery expectations before treatment.